Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.60 | 1.22 | 0.62 |
Stocks | 99.39 | 99.41 | 0.02 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.78 | 20.04 |
Price to Book | 4.31 | 4.09 |
Price to Sales | 2.40 | 2.44 |
Price to Cash Flow | 17.33 | 16.42 |
Dividend Yield | 1.83 | 1.36 |
5 Years Earnings Growth | 13.15 | 12.53 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.58 | 94.84 |
Basic Materials | 0.32 | 1.32 |
Consumer Defensive | 0.06 | 3.24 |
Financial Services | 0.04 | 8.87 |
Number of long holdings: 186
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 783.49 | +2.20% | |
UnitedHealth | US91324P1021 | 6.67 | 532.94 | +0.60% | |
J&J | US4781601046 | 4.97 | 146.90 | +0.18% | |
AbbVie | US00287Y1091 | 4.65 | 170.41 | -0.15% | |
Novo Nordisk B | DK0062498333 | 4.42 | 622.4 | +7.13% | |
Merck&Co | US58933Y1055 | 3.31 | 95.70 | -0.97% | |
Roche Holding Participation | CH0012032048 | 2.86 | 274.90 | +0.18% | |
Novartis | CH0012005267 | 2.84 | 90.26 | 0.00% | |
Thermo Fisher Scientific | US8835561023 | 2.70 | 576.26 | +0.25% | |
Abbott Labs | US0028241000 | 2.54 | 124.93 | +1.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust I Dist | 8.25B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust C Acc | 8.25B | 27.25 | 11.20 | 15.12 | ||
Legal General US Index Trust C Dist | 8.25B | 27.22 | 11.20 | 15.12 | ||
Legal General US Index Trust F Acc | 587.46K | 26.93 | 10.90 | 14.79 | ||
Legal General US Index Trust F Dist | 24.82K | 26.85 | 10.88 | 14.78 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review